Human monoclonal antibody against group A red blood cells

Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4351721, 436548, 424 11, 935 81, 935 89, 935 93, 935 96, 935 99, 935102, 935103, 530387, G01N 3353, G12N 1500

Patent

active

047644656

ABSTRACT:
A human monoclonal antibody that directly agglutinates type A human red blood cells is described. The exemplified antibody is an IgM and is produced by hybrid cells lines S-H22 and HHA1. The antibody is useful as an ABO typing reagent.

REFERENCES:
patent: 4451570 (1984-05-01), Royston et al.
patent: 4608337 (1986-08-01), Croce
patent: 4618486 (1986-10-01), Lundblad
patent: 4618577 (1986-10-01), Handley et al.
patent: 4634664 (1987-01-01), Oestberg
patent: 4634666 (1987-01-01), Engleman et al.
Abe et al., The Antibody Specific to Type 1 Chain Blood Group A Determinant, The Journal of Immunology, 132 (4), Apr. 1984, 1951-1954.
Voak, D. et al., Vox Sang, vol. 39, pp. 134-140, 1980.
Edelman et al., Immunology, vol. 44, No. 3, 549-554, 1981 (Abstract).
Chemical Abstracts, vol. 100, 190042u, 1984.
Chemical Abstracts, vol. 100, 101320t, 1984.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human monoclonal antibody against group A red blood cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human monoclonal antibody against group A red blood cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibody against group A red blood cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-600383

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.